Each batch undergoes internal identity, purity, and appearance checks before release
Side Effects & Safety Mild GI discomfort most common, usually transient in the first week Slight stimulant effect increased energy/alertness, especially early on Headaches occasional, typically mild and dose-related Mild insomnia if taken too late in the day No human clinical safety data all safety information from preclinical studies and community reports No liver toxicity observed in animal studies at therapeutic doses Unknown drug interactions theoretically could interact with NAD+-dependent pathways Core Supplies for This Protocol The essentials for running any reconstituted injectable: cold storage, accurate syringes, alcohol prep pads, and metabolic tracking
Individuals with gastrointestinal conditions Crohns disease, celiac disease, and other inflammatory bowel conditions impair absorption
Push your boundaries withTesofensine, a premium compound engineered specifically for the STA Formulations research-oriented line
Please click here to buy
Case reports document hypertensive crises, tachycardia exceeding 140 bpm, and one acute myocardial ischemia event in a 34-year-old with no prior cardiac history
